Discontinued — last reported Q3 '25
Idexx Laboratories Intangibles (Net) decreased by 4.6% to $104.75M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.5%, from $107.41M to $104.75M. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows an upward trend with a 15.9% CAGR.
An increase often follows strategic acquisitions or significant R&D capitalization, while a decrease may indicate amortization or impairment charges.
This represents the net book value of non-physical assets, such as patents, trademarks, software, and customer relations...
Highly relevant for healthcare and technology firms; peers often disclose the composition of these assets in financial footnotes.
intangible_assets_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $96.76M | $94.98M | $99.04M | $105.19M | $100.59M | $99.97M | $97.67M | $94.36M | $90.93M | $87.13M | $84.50M | $115.35M | $110.81M | $106.89M | $111.68M | $107.41M | $103.73M | $114.79M | $109.84M | $104.75M |
| QoQ Change | — | -1.8% | +4.3% | +6.2% | -4.4% | -0.6% | -2.3% | -3.4% | -3.6% | -4.2% | -3.0% | +36.5% | -3.9% | -3.5% | +4.5% | -3.8% | -3.4% | +10.7% | -4.3% | -4.6% |
| YoY Change | — | — | — | — | +4.0% | +5.3% | -1.4% | -10.3% | -9.6% | -12.8% | -13.5% | +22.2% | +21.9% | +22.7% | +32.2% | -6.9% | -6.4% | +7.4% | -1.6% | -2.5% |